The largest database of trusted experimental protocols

Methyl thiazolyl tetrazolium (mtt)

Manufactured by Tokyo Chemical Industry
Sourced in Japan

The MTT is a colorimetric assay used to measure cell proliferation, viability and cytotoxicity. It utilizes the yellow tetrazolium salt MTT, which is reduced by metabolically active cells to form purple formazan crystals. The amount of formazan produced is directly proportional to the number of viable cells in the sample.

Automatically generated - may contain errors

10 protocols using methyl thiazolyl tetrazolium (mtt)

1

Cell Viability Assay using MTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded into 96-well plates at a density of 3000 cells per well and cultured for the indicated times. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Tokyo Chemical Industry, Tokyo, Japan; D0801) method. Briefly, 10 μL of 12 mM MTT solution was added to each well, incubated for 3 h, and the reaction was stopped by adding 100 μL of STOP solution [2% acetic acid, 16% SDS (Wako, Osaka, Japan; 194-13985), and 42% N, N-dimethyl formamide (Nakalai Tesque, Kyoto, Japan; 13016-65)], as previously described [13 (link)]. Samples were mixed thoroughly and measured at 570 nm for absorbance.
+ Open protocol
+ Expand
2

Evaluating Cell Viability by MTT Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was measured based on the formation of colored formazan crystal from MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Tokyo Chemical Industry, Tokyo, Japan). Briefly, cells were grown in supplemented DMEM media in a 96-well plate until reaching ~70% confluency. Supplemented media was replaced with serum-free media, and then cells were treated with nanoparticles (1.56–100 µg/mL) for 24 h. MTT was solubilized in sterile PBS and added to cells (a final concentration of 500 µg/mL) for ~1–3 h or until blue formazan crystals formed. The supernatant was discarded and the crystals were dissolved in isopropyl alcohol (IPA). After placing the microplate on a shaker for 10 min, absorbance was measured by a spectrophotometer at a wavelength of 570 nm (Synergy HT system, BioTek, Winooski, VT, USA).
+ Open protocol
+ Expand
3

Molecular Mechanisms of ICAM-1 and LDLR Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ribavirin (>98% purity) and MTT were purchased from Tokyo Chemical Industry (Tokyo, Japan) and Sigma-Aldrich (St. Louis, MO), respectively. Anitbiotic-antimycotic and minimum essential medium (MEM) were purchased from Invitrogen (Grand Island, NY). Fetal bovine serum (FBS) was supplied by PAA Laboratories (Etobicoke, Ontario, Canada). The protein molecular weight standards (Precision Plus Protein all blue standards) were purchased from Bio-Rad Life Sciences (Hercules, CA). RIPA buffer and 1% mammalian cell protease inhibitor cocktail were purchased from Sigma-Aldrich. The primary antibodies used in this study were as follows: anti-ICAM-1 antibody [rabbit polyclonal to intercellular adhesion molecule-1 (ICAM-1)], anti-low-density lipoprotein receptor (LDLR) antibody (rabbit polyclonal to LDLR), and anti-actin antibody (rabbit polyclonal to actin) purchased from Abcam (Cambridge, UK). The secondary antibody (horseradish peroxidase conjugated goat polyclonal to rabbit) was supplied by Abcam. All of the other chemicals and reagents used in this study were of analytical grade quality and available commercially.
+ Open protocol
+ Expand
4

TM Dose and Treatment Time Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentration and treatment time of TM (# 5045700001; Sigma Corporation, Missouri, United States) were screened by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (# D0801; Tokyo Chemical Industry, Tokyo, Japan) method. The cells were divided into four groups after synchronization and treated with 0, 1, 2, and 4 μg/ml TM for 24 h, respectively. Twenty microliters of MTT was added to the cells in the dark, and they were incubated at 37 C with 5% CO2 for 4 h. One hundred fifty microliters of dimethyl sulfoxide (DMSO) solution per well was added to the cells after discarding the culture medium. After the HSCs were oscillated at low speed for 10 min, the absorbance (OD) value was read and the proliferation rate (PR) (PR = T/C × 100%, T was the OD value of the treatment group, and C was the OD value of the 0 μg/ml TM group) was calculated after adjusting the wavelength of the plate analyzer to 490 nm. The cells were divided into three groups after synchronization and treated with 2 μg/ml TM for 12, 24, and 36 h, respectively. The OD value was detected by the same method as above.
+ Open protocol
+ Expand
5

MTT Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
HaCaT cells were seeded into 96-well plate at a density 1 × 105 cells/mL and were incubated overnight at 37 °C in humidified atmosphere of 5% CO2. Then, the cells were treated with isolated compounds at various concentrations for 24 h. Subsequently, 10 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, purchased from Tokyo Chemical Industry, Tokyo, Japan) solution (5 mg/mL in phosphate buffered saline, PBS) was added to each well and incubated for additional 4 h. Then, supernatant was discarded, and 40 mM HCl-isopropanol (100 μL) was added to dissolve formazan crystals. The absorbance was measured at 570 nm using microplate reader. The percentage of cell viability measured in control cells treated with DMSO without samples was used to calculate cell viability.
+ Open protocol
+ Expand
6

BeWo Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
BeWo cells were seeded at 1.0 × 10 4 cells/200 µL per well into 96-well flat plates and then treated with 50 µM forskolin with or without silver or gold nanoparticles for 48 h at 37 °C and >95% humidity under a 5% CO 2 atmosphere. Cell viability was measured with MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] (Tokyo Chemical Industry, Tokyo, Japan), in accordance with the manufacturers' instructions.
+ Open protocol
+ Expand
7

Cytotoxicity Evaluation via MTT Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed according to the standard protocol. Briefly, MTT (Tokyo Chemical Industry) solution was directly added to cells cultured in a 96-well plate. After 3 h of incubation, the medium was removed and the formazan product was dissolved in DMSO. Absorbance in each well was quantified with a Fusion plate reader (PerkinElmer, Waltham, MA). Nonlinear regression analysis and estimation of IC 50 were performed using R software (https://www.r-project.org/).
+ Open protocol
+ Expand
8

Atrazine-Induced Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs exposed to Atrazine or vehicle were incubated with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (TCI America, OR, USA) (0.5mg/ml final concentration) for five hours. Supernatants were removed and formazan crystals were dissolved with organic solvent. Optical densities were measured at 560 nm, and background at 670nm was subtracted.
+ Open protocol
+ Expand
9

MTT Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells cultured on a 96-well plate were incubated in medium containing 0.4 mg/mL 3-[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide (MTT; TCI America) at 37°C for 1 h. Reduced MTT was solubilized in DMSO (Sigma-Aldrich) for determination of absorbance at 570 nm.
+ Open protocol
+ Expand
10

Breast and Prostate Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MDA-MB-231 and MDA-MB-468 breast cancer and PC-3 prostate cancer cell lines were purchased from American Type Culture Collection (Manassas, VA). Media used for the maintenance of these cells were as follows: MDA-MB-231 and MDA-MB-468, DMEM; PC-3, RPMI 1640, all of which were supplemented with 10% fetal bovine serum. Cells were incubated at 37°C in a humidified incubator containing 5% CO2. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] was obtained from TCI America (Portland, OR), and the ECL Western Blotting System from GE Healthcare Life Sciences (Pittsburgh, PA). Antibodies specific for the following protein targets were used: p-Thr172-AMPK, AMPK, p-Thr389-p70S6K, p70S6K, Ser473-Akt, Akt, Foxo3a, claudin-1, vimentin, snail, and β-actin (Cell Signaling Technology, Inc., Beverly, MA); E-cadherin, BD Biosciences (San Diego, CA). Alexa Fluor 555- and 488-conjugated goat anti-rabbit and anti-mouse IgG were purchased from Invitrogen (Carlsbad, CA), and anti-mouse and anti-rabbit secondary antibodies was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!